Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ProgenaBiome
With
Rinati Skin, LLC
In this Phase I open-label interventional study we will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection. Patients being treated will have severe respiratory symptoms that are at or near requiring the patient be placed on a ventilator.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Critically ill patients with SARS from COVID-19 infection on respirators OR
2. Patients with SARS from COVID-19 infection prior or after being placed on respirator
3. Male or female patients 18 years of age and older
You may not be if
1\. Patients less than 18 years of age
Clareo Health | A Study of ResCure™ to Treat COVID-19 Infection
